Direkt zum Inhalt
Merck

STS0212

Sigma-Aldrich

ECO BRIJ® L4

greener alternative

average Mn ~362

Synonym(e):

Brij® L4, Polyethylenglykol-dodecylether, Polyoxyethylen(4)-laurylether

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

Lineare Formel:
(C20H42O5)n
CAS-Nummer:
MDL-Nummer:
UNSPSC-Code:
12165104
NACRES:
NA.28

Beschreibung

non-ionic

Qualitätsniveau

Form

semisolid (may be liquid)

Mol-Gew.

average Mn ~362

Grünere Alternativprodukt-Eigenschaften

Use of Renewable Feedstocks
Design for Degradation
Learn more about the Principles of Green Chemistry.

sustainability

Greener Alternative Product

Verunreinigungen

≤1.0% water

Brechungsindex

n20/D 1.451 (lit.)

mp (Schmelzpunkt)

48 °C

Säurezahl

≤2.0 mg KOH/g

Hydroxylzahl

144‑165 mg KOH/g

Löslichkeit

water: insoluble

Dichte

0.95 g/mL at 25 °C (lit.)

HLB

9.7

Grünere Alternativprodukt-Kategorie

SMILES String

CCCCCCCCCCCCOCCOCCOCCOCCO

InChI

1S/C20H42O5/c1-2-3-4-5-6-7-8-9-10-11-13-22-15-17-24-19-20-25-18-16-23-14-12-21/h21H,2-20H2,1H3

InChIKey

WPMWEFXCIYCJSA-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Allgemeine Beschreibung

ECO Brij® L4, also known as polyethylene glycol lauryl ether, is a bio-based, nonionic surfactant manufactured from naturally occurring straight-chain lauryl alcohol. This detergent, derived from natural sources, provides various functional advantages, such as detergency, emulsification, and wetting, making it suitable for a range of applications in biochemical and biological research.
We are committed to bringing you Greener Alternative Products, which adhere to one or more of The 12 Principles of Green Chemistry. This product is a biobased surfactant and is aligned with the 7th principle of Green Chemistry "Use of Renewable Feedstocks" and the 10th principle "Design for Degradation".

Leistungsmerkmale und Vorteile

  • 100 % Renewable
  • 100 % Bio-based
  • Certified to the USDA BioPreferred Program
  • Lower carbon footprint than petrochemical-based versions
  • High-purity chemical suitable for a wide variety of research applications

Physikalische Eigenschaften

The ECO Brij series of ethoxylated fatty alcohols are non-ionic surfactants manufactured using renewable sources. ECO Brij L4 is a mixture of tetraethylene glycol alkyl ethers, primarily dodecyl (C12) ether. The alkyl ether profile of ECO Brij L4 may differ lot-to-lot due to natural variability in the lipid starting material (palm oil).

Sonstige Hinweise

For additional information on our range of Biochemicals, please complete this form.

Rechtliche Hinweise

Brij is a registered trademark of Croda International PLC
ECO BRIJ is a registered trademark of Croda Inc.

Piktogramme

Exclamation markEnvironment

Signalwort

Warning

Gefahreneinstufungen

Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Skin Irrit. 2

Lagerklassenschlüssel

10 - Combustible liquids

WGK

WGK 2

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Leider sind derzeit keine COAs für dieses Produkt online verfügbar.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Jacomina W van den Esschert et al.
Annals of surgery, 255(2), 311-318 (2012-01-14)
To compare the safety and hypertrophy response after portal vein embolization (PVE) using 2 absorbable and 3 permanent embolization materials. Portal vein embolization is used to increase future remnant liver volume preoperatively. Application of temporary, absorbable embolization materials could be
Otte Brosjö et al.
Acta orthopaedica, 84(5), 502-505 (2013-11-01)
Recent data suggest that percutaneous sclerotherapy is a safe alternative to surgery for treatment of aneurysmal bone cysts (ABCs). We present our experience of this method. We retrospectively analyzed data from 38 consecutive patients treated with repeated injections of polidocanol.
Stefanie Reich-Schupke et al.
VASA. Zeitschrift fur Gefasskrankheiten, 42(1), 50-55 (2013-02-07)
According to the current guidelines for sclerotherapy hypercoagulability and thrombophilia with or without deep venous thrombosis are seen as relative contraindication for this treatment. But often such patients have an indication for a sclerotherapy. Recommendations for additional anticoagulation for sclerotherapy
A Erkin et al.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 44(6), 593-597 (2012-11-06)
Foam sclerosants are widely used in sclerotherapy and have been accepted as more effective than the liquid form; however, there is no consensus about the most applicable and effective concentration. The aim of this study was to investigate the histopathological
Takashi Yamaki et al.
Journal of vascular surgery, 56(6), 1649-1655 (2012-05-23)
This study assessed changes in the calf muscle deoxygenated hemoglobin (HHb) level during light-intensity exercise after ultrasound-guided foam sclerotherapy (UGFS) for superficial venous insufficiency. UGFS with 1% or 3% polidocanol foam (POL-F) was used to treat unilateral great saphenous vein

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.